This site is only for UK healthcare professionals and contains promotional information.


Prescribing Information and adverse event reporting can be found at the bottom of the page.

Welcome to Almirall

Driven by science and committed to patients

This is the philosophy which inspires Almirall to keep addressing the unmet needs of people living with skin conditions.

Our goal is to have a 360º approach to patient care, considering both physical symptoms and those closely associated with wellbeing and mental health. Ultimately, contributing to us becoming a leader in dermatology.

dermatology diagram

Pushing for breakthroughs in dermatology – our therapeutic focus

The focus of our innovation is clear: to find solutions that help people with skin diseases. We invest in innovative biologics and cutting edge treatments to improve patients’ lives.


Stay up-to-date with develpoments in dermatlogoy

Realising the ambition

Please click below if you would like more information on our products.

Old man with head graphic


Indicated for the field treatment of nonhyperkeratotic, non-hypertrophic actinic keratosis (grade 1) of the face or scalp in adults.1

Woman kicking water


The first and only CAL/BDP cream that treats mild to moderate psoriasis vulgaris on the body and scalp.2,3

Woman in bathing suit


Indicated for the treatment of adults with
moderate to severe plaque psoriasis who are candidates for systemic therapy.4

Asset 3


Indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years of age and older with a body weight of at least 40 kg who are candidates for systemic therapy.5

1. KLISYRI® SmPC. Almirall. 2. WYNZORA® SmPC. Almirall. 3. Praestegard M, et al. Dermatol Ther (Heidelb). 2022;12(10):2217-31. 4. ILUMETRI® SmPC. Almirall. 5. Ebglyss SmPC. Almirall.

UK-ILU-2400006 July 2024

This is a promotional website intended for UK healthcare professionals only (HCPs). Please confirm you are a healthcare professional before accesing the content.

Leaving AlmirallMED

Dear user,

You are leaving the website Specific policies may apply on the new website you are visiting, all interactions with that website are your sole responsibility.